Channel Medsystems

Channel Medsystems, founded in 2003, is a commercial-stage medical device company addressing the significant unmet need in heavy menstrual bleeding (HMB), which affects 1 in 5 women. Its flagship product, the Cerene® Cryotherapy device, offers a quick, incision-free endometrial ablation performed in a physician's office without general anesthesia, supported by strong 3-year clinical data showing high efficacy and patient satisfaction. The company's mission is to empower women by providing a convenient, effective treatment that restores quality of life and control.

Endometrial Cryoablation: A single-use device that delivers precise, uniform freezing to ablate the uterine lining in 2.5 minutes, performed in-office without general anesthesia or incisions.

Competes in the endometrial ablation market against established players like Boston Scientific (NovaSure), Medtronic (Her Option), and Hologic (Thermachoice). Key differentiators are Cerene's office-based procedure without anesthesia, short treatment time, and demonstrated preservation of hysteroscopic cavity access post-treatment.